Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-18-003136
Filing Date
2018-03-26
Accepted
2018-03-26 17:25:57
Documents
80
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 MONOPAR THERAPEUTICS INC. mnpr_form10k.htm 10-K 1437668
2 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION exhibit_3-1.htm EX-3.1 32698
3 AMENDED AND RESTATE BYLAWS exhibit_3-2.htm EX-3.2 85426
4 CANCER RESEARCH UK CTOA exhibit_10-1.htm EX-10.1 993425
5 XOMA LICENSE AGREEMENT exhibit_10-2.htm EX-10.2 175441
6 ONXEO OPTION AND LICENSE AGREEMENT exhibit_10-3.htm EX-10.3 379198
7 TACTICGEM CONTRIBUTION AGREEMENT exhibit_10-4.htm EX-10.4 217527
8 MONOPAR THERAPEUTICS INC. 2016 STOCK INCENTIVE PLAN exhibit_10-5.htm EX-10.5 246071
9 ROBINSON EMPLOYMENT AGREEMENT exhibit_10-6.htm EX-10.6 110593
10 ROBINSON EMPLOYMENT AGREEMENT AMENDED AND RESTATED exhibit_10-7.htm EX-10.7 104167
11 TSUCHIMOTO CONSULTING AGREEMENT exhibit_10-8.htm EX-10.8 103203
12 TSUCHIMOTO EMPLOYMENT AGREEMENT exhibit_10-9.htm EX-10.9 90577
13 MAZAR CONSULTING AGREEMENT exhibit_10-10.htm EX-10.10 52868
14 MAZAR EMPLOYMENT AGREEMENT exhibit_10-11.htm EX-10.11 113660
15 PRX CONSULTING AGREEMENT 2017 exhibit_10-12.htm EX-10.12 98459
16 ANDERSON EMPLOYMENT AGREEMENT exhibit_10-13.htm EX-10.13 178408
17 PRX CONSULTING AGREEMENT 2018 exhibit_10-14.htm EX-10.14 65646
18 TSUCHIMOTO EMPLOYMENT AGREEMENT AMENDMENT ONE exhibit_10-15.htm EX-10.15 11368
19 CANCER RESEARCH UK LETTER DATED MARCH 21, 2018 exhibit_10-16.htm EX-10.16 15232
20 STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS exhibit_11.htm EX-11 2218
21 CODE OF BUSINESS CONDUCT AND ETHICS exhibit_14.htm EX-14 110743
22 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit_31-1.htm EX-31.1 9706
23 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit_31-2.htm EX-31.2 9191
24 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit_32-1.htm EX-32.1 8854
25 IMAGE abpi_logo.jpg GRAPHIC 3839
26 IMAGE cruklogo.jpg GRAPHIC 12749
27 IMAGE exhibit_10-1001.jpg GRAPHIC 8871
28 IMAGE exhibit_10-1003.jpg GRAPHIC 26772
29 IMAGE logos3.jpg GRAPHIC 33529
30 IMAGE mnpr_form10k000.jpg GRAPHIC 22335
31 IMAGE onxeo_logo.jpg GRAPHIC 4649
  Complete submission text file 0001654954-18-003136.txt   6651893

Data Files

Seq Description Document Type Size
32 XBRL INSTANCE DOCUMENT mono-20171231.xml EX-101.INS 374317
33 XBRL TAXONOMY EXTENSION SCHEMA mono-20171231.xsd EX-101.SCH 22782
34 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mono-20171231_cal.xml EX-101.CAL 45549
35 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mono-20171231_def.xml EX-101.DEF 49820
36 XBRL TAXONOMY EXTENSION LABEL LINKBASE mono-20171231_lab.xml EX-101.LAB 186888
37 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mono-20171231_pre.xml EX-101.PRE 147225
Mailing Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062
Business Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062 6143958936
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-55866 | Film No.: 18713576
SIC: 2834 Pharmaceutical Preparations